PRM-151 in Myelofibrosis: Durable Efficacy and Safety at 72 Weeks

Authors
Category Primary study
JournalBlood
Year 2015
This article has no abstract
Epistemonikos ID: 49c0faae45eaa58cf7d742a893a947babb54740e
First added on: Feb 19, 2025